Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
India Globalization Capital Inc
(NY:
IGC
)
0.4600
-0.0210 (-4.37%)
Official Closing Price
Updated: 8:00 PM EDT, Jul 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about India Globalization Capital Inc
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
420 with CNW — FDA Seeks More Data in Fight Against Delta-8 THC Products
December 16, 2022
Via
CannabisNewsWire
Topics
Cannabis
Derivatives
Exposures
Cannabis
Derivatives
Product Safety
Research Links Diets High in Fat to Chronic Pain
December 15, 2022
Via
Investor Brand Network
420 with CNW — DOJ Requests Additional Time in Cannabis Consumption Sites Case
December 14, 2022
Via
Investor Brand Network
Topics
Cannabis
Government
Law Enforcement
Exposures
Cannabis
Financial
Legal
420 with CNW — DOJ Requests Additional Time in Cannabis Consumption Sites Case
December 14, 2022
Via
CannabisNewsWire
Topics
Cannabis
Government
Law Enforcement
Exposures
Cannabis
Financial
Legal
420 with CNW — Colorado Regulators Allow Medical Cannabis to Be Recategorized as Recreational Marijuana
December 12, 2022
Via
CannabisNewsWire
Topics
Cannabis
Exposures
Cannabis
The Future Of The Indian Market
June 19, 2022
India has an estimated 26,000 startups, making it the third-largest startup ecosystem in the world, recording consolidated inflows of over $36 billion in the past 3 years.
Via
Talk Markets
420 with CNW — Colorado Regulators Allow Medical Cannabis to Be Recategorized as Recreational Marijuana
December 12, 2022
Via
Investor Brand Network
Topics
Cannabis
Exposures
Cannabis
Existing Drug May Alleviate Side Effects of Cancer Treatment
December 09, 2022
Via
Investor Brand Network
420 with CNW — New Study Finds Medical Cannabis Legalization Reduces Use of Opioids by Cancer Patients
December 08, 2022
Via
Investor Brand Network
Topics
Cannabis
Exposures
Cannabis
420 with CNW — New Study Finds Medical Cannabis Legalization Reduces Use of Opioids by Cancer Patients
December 08, 2022
Via
CannabisNewsWire
Topics
Cannabis
Exposures
Cannabis
CannabisNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Applauds Milestone Development for Medical Cannabis Industry
December 07, 2022
Via
Investor Brand Network
Topics
Cannabis
Exposures
Cannabis
CannabisNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Applauds Milestone Development for Medical Cannabis Industry
December 07, 2022
Via
CannabisNewsWire
Topics
Cannabis
Exposures
Cannabis
BioMedNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Commences Trial Evaluating IGC-AD1 for the Treatment of Alzheimer’s-Related Symptoms
December 02, 2022
Via
Investor Brand Network
Exposures
Product Safety
BioMedNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) to Present at RHK 2022 Disruptive Growth Conference
December 01, 2022
Via
Investor Brand Network
IGC Starts Phase 2 Clinical Trials Of THC Based Drug Candidate For The Treatment Of Agitation In Dementia From Alzheimer's Disease
December 01, 2022
India Globalization Capital, Inc. (AMEX:IGC) has begun “A phase 2, multi-center, double-blind, randomized, placebo-controlled, trial of the safety and efficacy of IGC-AD1 on agitation in participants...
Via
Benzinga
IGC Commences Phase 2 Clinical Trials Evaluating Drug Candidate IGC-AD1 for the Treatment of Agitation in Dementia From Alzheimer’s Disease
December 01, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
InvestorNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Releases Financial Numbers for Q2
November 02, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
India Globalization Capital Inc. (NYSE American: IGC) Is ‘One to Watch’
November 02, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
IGC Q2 2023 Revenue Grows 261%, THC Based Drug For Alzheimer's Entering Phase 2 Trials
November 02, 2022
India Globalization Capital, Inc. (AMEX:IGC) reported its second fiscal quarter 2023 financial results, revealing revenue of $202,000, a 261% increase compared to $56,000 in the same quarter of 2022.
Via
Benzinga
IGC Reports Financial Results for Second Fiscal Quarter Ended Sept. 30, 2022
November 01, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
September 28, 2022
It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning.
Via
InvestorPlace
IGC Announces Issuance Of Second Patent For The Treatment Of Alzheimer's Using THC
September 21, 2022
India Globalization Capital, Inc. (AMEX:IGC) announced that the United States Patent and Trademark Office issued a second patent (#11,446,276) for the treatment of Alzheimer’s disease entitled “Extreme...
Via
Benzinga
IGC Announces Issuance of Second Patent for the Treatment of Alzheimer’s Using THC
September 21, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
IGC Announces Results of its 2022 Annual Stockholders Meeting
September 12, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
IGC Stock Slightly Up On Q1 2023 Revenue Growth Of 175%, What About Gross Profit?
August 08, 2022
India Globalization Capital, Inc. (AMEX:IGC) revenue in Q1 2023 was approximately $212,000 an increase of 175% compared to $77,000 in the same quarter of 2022.
Via
Benzinga
IGC Reports Financial Results for the Quarter Ended June 30, 2022
August 08, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
IGC Revenue Drops 55.8% In Fiscal 2022, What About Gross Profit?
June 23, 2022
India Globalization Capital, Inc. (AMEX:IGC) revenue in fiscal 2022 was $397,000, a 55.8% decrease compared to $898,000 in fiscal 2021.
Via
Benzinga
IGC Reports Financial Results for Fiscal Year Ended March 31, 2022
June 22, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
IGC Acquires Exclusive Rights For A Potential Alzheimer's Drug Development Candidate
June 21, 2022
One of subsidiaries of India Globalization Capital, Inc. (NYSE: IGC) reached an intellectual property license agreement for a potential Alzheimer’s drug development candidate.
Via
Benzinga
IGC Acquires Exclusive Rights for a Potential Alzheimer’s Drug Development Candidate
June 21, 2022
From
India Globalization Capital, Inc.
Via
Business Wire
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.